HucMSCs can alleviate abnormal vasculogenesis induced by high glucose through the MAPK signaling pathway

Summary: Vascular complications caused by diabetes mellitus contribute a major threat to increased disability and mortality of diabetic patients, which are characterized by damaged endothelial cells and angiogenesis. Human umbilical cord-derived mesenchymal stem cells (hucMSCs) have been demonstrate...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang Yao, Tiantian Shan, Xiaoying Li
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004224025793
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846113153060962304
author Yang Yao
Tiantian Shan
Xiaoying Li
author_facet Yang Yao
Tiantian Shan
Xiaoying Li
author_sort Yang Yao
collection DOAJ
description Summary: Vascular complications caused by diabetes mellitus contribute a major threat to increased disability and mortality of diabetic patients, which are characterized by damaged endothelial cells and angiogenesis. Human umbilical cord-derived mesenchymal stem cells (hucMSCs) have been demonstrated to alleviate endothelial cell damage and improve angiogenesis. However, these investigations overlooked the pivotal role of vasculogenesis. In this study, we utilized blood vessel organoids (BVOs) to investigate the impact of high glucose on vasculogenesis and subsequent angiogenesis. We found that BVOs in the vascular lineage induction stage were more sensitive to high glucose and more susceptible to affect endothelial cell differentiation and function. Moreover, hucMSCs can alleviate the high glucose-induced inhibition of endothelial cell differentiation and dysfunction through MAPK signaling pathway downregulation, with the MAPK activator dimethyl fumarate further illustrating the results. Thereby, we demonstrated that high glucose can lead to abnormal vasculogenesis and impact subsequent angiogenesis, and hucMSCs can alleviate this effect.
format Article
id doaj-art-7feeb0a903e749fba03cbc9decc3d554
institution Kabale University
issn 2589-0042
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series iScience
spelling doaj-art-7feeb0a903e749fba03cbc9decc3d5542024-12-22T05:29:03ZengElsevieriScience2589-00422024-12-012712111354HucMSCs can alleviate abnormal vasculogenesis induced by high glucose through the MAPK signaling pathwayYang Yao0Tiantian Shan1Xiaoying Li2Department of Anesthesiology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao 266011, China; Research Center of Translational Medicine, Central Hospital Affiliated Shandong First Medical University, Jinan 250013, ChinaResearch Center of Translational Medicine, Central Hospital Affiliated Shandong First Medical University, Jinan 250013, China; Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao 266000, ChinaResearch Center of Translational Medicine, Central Hospital Affiliated Shandong First Medical University, Jinan 250013, China; Department of Emergency, Jinan Central Hospital, Jinan 250013, China; Department of Emergency, Central Hospital Affiliated Shandong First Medical University, Jinan 250013, China; Corresponding authorSummary: Vascular complications caused by diabetes mellitus contribute a major threat to increased disability and mortality of diabetic patients, which are characterized by damaged endothelial cells and angiogenesis. Human umbilical cord-derived mesenchymal stem cells (hucMSCs) have been demonstrated to alleviate endothelial cell damage and improve angiogenesis. However, these investigations overlooked the pivotal role of vasculogenesis. In this study, we utilized blood vessel organoids (BVOs) to investigate the impact of high glucose on vasculogenesis and subsequent angiogenesis. We found that BVOs in the vascular lineage induction stage were more sensitive to high glucose and more susceptible to affect endothelial cell differentiation and function. Moreover, hucMSCs can alleviate the high glucose-induced inhibition of endothelial cell differentiation and dysfunction through MAPK signaling pathway downregulation, with the MAPK activator dimethyl fumarate further illustrating the results. Thereby, we demonstrated that high glucose can lead to abnormal vasculogenesis and impact subsequent angiogenesis, and hucMSCs can alleviate this effect.http://www.sciencedirect.com/science/article/pii/S2589004224025793PathophysiologyStem cells researchVascular remodeling
spellingShingle Yang Yao
Tiantian Shan
Xiaoying Li
HucMSCs can alleviate abnormal vasculogenesis induced by high glucose through the MAPK signaling pathway
iScience
Pathophysiology
Stem cells research
Vascular remodeling
title HucMSCs can alleviate abnormal vasculogenesis induced by high glucose through the MAPK signaling pathway
title_full HucMSCs can alleviate abnormal vasculogenesis induced by high glucose through the MAPK signaling pathway
title_fullStr HucMSCs can alleviate abnormal vasculogenesis induced by high glucose through the MAPK signaling pathway
title_full_unstemmed HucMSCs can alleviate abnormal vasculogenesis induced by high glucose through the MAPK signaling pathway
title_short HucMSCs can alleviate abnormal vasculogenesis induced by high glucose through the MAPK signaling pathway
title_sort hucmscs can alleviate abnormal vasculogenesis induced by high glucose through the mapk signaling pathway
topic Pathophysiology
Stem cells research
Vascular remodeling
url http://www.sciencedirect.com/science/article/pii/S2589004224025793
work_keys_str_mv AT yangyao hucmscscanalleviateabnormalvasculogenesisinducedbyhighglucosethroughthemapksignalingpathway
AT tiantianshan hucmscscanalleviateabnormalvasculogenesisinducedbyhighglucosethroughthemapksignalingpathway
AT xiaoyingli hucmscscanalleviateabnormalvasculogenesisinducedbyhighglucosethroughthemapksignalingpathway